UK loses measles elimination status

THE UK has lost its measles elimination status

At its 14th meeting, the European Regional Verification Commission for Measles and Rubella Elimination (RVC) emphasized that measles and rubella elimination and verification remain priorities for the WHO European Region and globally.

Based on reports submitted for 2024 and previous years, the RVC concluded that: 

  • 32 (60%) Member States provided evidence to demonstrate the elimination of endemic measles (interruption for at least 36 months) and 49 (92%) to demonstrate the elimination of endemic rubella, and 32 (60%) Member States provided evidence of the elimination of both measles and rubella; 
  • one Member State interrupted measles transmission for 12 months;  
  • 13 (25%) Member States were considered endemic for measles; 
  • 6 (11%) Member States were considered to have re-established measles transmission; and
  • the rubella elimination status of 3 (6%) Member States is subject to the provision of additional data. 

The RVC noted with concern the loss of measles elimination status in some Member States, including some with high-performing immunization programmes. The situation in 2024 highlighted the urgent need for increased political and financial commitment from countries and international organizations.

Considering the vast majority of reported cases were among unimmunized individuals, the RVC reiterated that to achieve measles and rubella elimination, as recommended by WHO, sustained coverage of at least 95% with 2 doses of measles- and rubella-containing vaccines is needed.

The RVC encouraged all Member States to increase activities to achieve sufficient immunization coverage and close all remaining immunity gaps, focusing especially on vulnerable and hard-to-reach populations. The RVC also encouraged all Member States to enhance surveillance systems to improve case detection and capture more epidemiological and laboratory data to allow adequate analysis and the identification of transmission chains and outbreak sources.

The RVC is also concerned with the absence of the timely detection of and adequate immunization response to measles outbreaks, which are critical to stop measles virus transmission once the virus has been imported into a population with susceptible individuals.

The further building of response capacities, and understanding of the consequences if adequate response measures, including immunization, are not taken on time, must be priorities for health systems and decision-makers in all Member States. 

The 14th RVC meeting report, including the full text of conclusions and recommendations, is pending publication.

Table: RVC conclusions on measles and rubella elimination status per Member State for 2024

Member StateMeaslesRubella
AlbaniaEliminatedEliminated
AndorraEliminatedEliminated
ArmeniaRe-establishedEliminated
AustriaRe-establishedEliminated
AzerbaijanRe-establishedEliminated
BelarusEliminatedEliminated
BelgiumEliminatedEliminated
Bosnia and HerzegovinaEndemicSubject to provision of additional data
BulgariaEliminatedEliminated
CroatiaEliminatedEliminated
CyprusEliminatedEliminated
CzechiaEliminatedEliminated
DenmarkEliminatedEliminated
EstoniaEliminatedEliminated
FinlandEliminatedEliminated
FranceEndemicEliminated
GeorgiaEndemicEliminated
GermanyEndemicEliminated
GreeceEliminatedEliminated
HungaryEliminatedEliminated
IcelandEliminatedEliminated
IrelandEliminatedEliminated
IsraelNo reportNo report
ItalyEndemicEliminated
KazakhstanEndemicEliminated
KyrgyzstanEndemicEliminated
LatviaEliminatedEliminated
LithuaniaEliminatedEliminated
LuxembourgEliminatedEliminated
MaltaEliminatedEliminated
MonacoEliminatedEliminated
MontenegroEliminatedEliminated
Netherlands (Kingdom of the)EliminatedEliminated
North MacedoniaEliminatedEliminated
NorwayEliminatedEliminated
PolandEndemicSubject to provision of additional data
PortugalEliminatedEliminated
Republic of MoldovaEliminatedEliminated
RomaniaEndemicEliminated
Russian FederationEndemicEliminated
San MarinoEliminatedEliminated
SerbiaEndemicEliminated
SlovakiaEliminatedEliminated
SloveniaEliminatedEliminated
SpainRe-establishedEliminated
SwedenEliminatedEliminated
SwitzerlandEliminatedEliminated
TajikistanInterrupted 12 monthsEliminated
TürkiyeEndemicEliminated
TurkmenistanEliminatedEliminated
UkraineEndemicSubject to provision of additional data
United KingdomRe-establishedEliminated
UzbekistanRe-establishedEliminated

UKHSA responds to the confirmation from @WHO that the UK has lost its measles elimination status:

Public Health Scotland: Changes to childhood vaccination programme

CHILDREN TO BE OFFERED CHICKENPOX VACCINE

Following a detailed review by the Joint Committee on Vaccination and Immunisation (JCVI), the UK’s independent expert group on vaccines, Public Health Scotland (PHS) has been working with the Scottish Government and colleagues across NHS Boards to make some changes to Scotland’s childhood vaccination programme.

The changes, which began in July 2025, are based on the latest scientific evidence and are designed to ensure that children continue to have the best possible protection from vaccine-preventable diseases. 

From January 2026, children will be offered a varicella (chickenpox) vaccine as part of the routine childhood schedule for the first time in Scotland.

JCVI’s recommendation is to offer a two-dose programme offering vaccination at 12 and 18 months of age, using the combined MMRV (measles, mumps, rubella and varicella) vaccine.

Varicella vaccines have been seen to dramatically decrease the number of cases of chickenpox seen in childhood when used in other countries.

Dr Daniel Chandler, Consultant in Public Health Medicine at PHS said:Chickenpox is a highly contagious infectious disease. While most cases of chickenpox in children are relatively mild, many children are unwell for several days and have to miss school or nursery as a result. In some cases, chickenpox can be more severe and can lead to hospitalisations from serious secondary infections or other complications.

“The offer of the varicella vaccine is a welcome new addition to the routine childhood schedule and, as well as reducing the number of cases, will prevent more severe cases of chickenpox.”

Vaccination programmes are regularly reviewed to make sure that all children are offered the best protection against preventable diseases. As new vaccines become available, or research shows that giving existing vaccines at different times improves protection, the programme will be changed.

Parents and carers will receive appointment invitations from local NHS immunisation teams and are encouraged to look out for them and bring their children for vaccination as scheduled.

Where to find more information:

Parents and carers who want to know more about the vaccinations offered to their children should visit nhsinform.scot/vaccinesforchildren

Information about the new MMRV programme is available at MMRV vaccine | NHS inform